Ma N, Pan Q, Qi Y, Shao F. Thrombosis in Severe Influenza A Pneumonia: Distribution and Risk Factors in Hangzhou, China. Infect Drug Resist. 2026;19:590329
Background: Severe viral pneumonia, including that caused by influenza A, can trigger a systemic inflammatory response that can lead to coagulation abnormalities, which substantially increases the risk of life-threatening thrombotic complications.
Objective: This study aimed to examine the distribution of thrombosis and its risk factors among patients with severe influenza A pneumonia to inform early clinical identification and intervention.
Methods: A retrospective analysis was performed on 175 patients with severe influenza A pneumonia who were admitted to the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine between January 2024 and March 2025. Patients were categorised into a thrombosis group (n = 82) and a control group (n = 93). Clinical data were analysed using univariate and multivariate logistic regression to identify independent risk factors.
Results: The thrombosis group showed significantly higher D-dimer (3.06 [0.95, 12.42] vs 0.90 [0.54, 1.53] μg/mL, p < 0.001) and prolonged prothrombin time (PT) (14.90 [13.56, 18.58] vs 13.70 [13.20, 14.50] s, p < 0.001) than the controls. Multivariate analysis identified elevated D-dimer (odds ratio [OR] = 1.016, p = 0.021) and decreased haemoglobin (OR = 1.026, p = 0.013) as independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis (OR = 0.751, p = 0.010). Venous thrombosis predominated (78.0%), with isolated muscular vein thrombosis (IMVT) being the most common subtype (36.6%).
Conclusion: This study clarified that venous thrombosis, predominantly IMVT and pulmonary embolism, is the primary thrombotic complication in severe influenza A pneumonia. We identified a unique biomarker profile for risk stratification; elevated D-dimer and decreased haemoglobin are independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis. This combination provides a practical tool for early clinical identification of patients at high risk, guiding tailored thromboprophylaxis.
Objective: This study aimed to examine the distribution of thrombosis and its risk factors among patients with severe influenza A pneumonia to inform early clinical identification and intervention.
Methods: A retrospective analysis was performed on 175 patients with severe influenza A pneumonia who were admitted to the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine between January 2024 and March 2025. Patients were categorised into a thrombosis group (n = 82) and a control group (n = 93). Clinical data were analysed using univariate and multivariate logistic regression to identify independent risk factors.
Results: The thrombosis group showed significantly higher D-dimer (3.06 [0.95, 12.42] vs 0.90 [0.54, 1.53] μg/mL, p < 0.001) and prolonged prothrombin time (PT) (14.90 [13.56, 18.58] vs 13.70 [13.20, 14.50] s, p < 0.001) than the controls. Multivariate analysis identified elevated D-dimer (odds ratio [OR] = 1.016, p = 0.021) and decreased haemoglobin (OR = 1.026, p = 0.013) as independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis (OR = 0.751, p = 0.010). Venous thrombosis predominated (78.0%), with isolated muscular vein thrombosis (IMVT) being the most common subtype (36.6%).
Conclusion: This study clarified that venous thrombosis, predominantly IMVT and pulmonary embolism, is the primary thrombotic complication in severe influenza A pneumonia. We identified a unique biomarker profile for risk stratification; elevated D-dimer and decreased haemoglobin are independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis. This combination provides a practical tool for early clinical identification of patients at high risk, guiding tailored thromboprophylaxis.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 6 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 6 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 6 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 6 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 6 hours ago
[Go Top] [Close Window]


